| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/21/2007 | EP1753454A1 Vaccine for periodontal disease |
| 02/21/2007 | EP1753453A2 Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist |
| 02/21/2007 | EP1753452A2 A method for altering the cd4/cd8 ratio and the mononuclear cellular infiltrate into a tumor |
| 02/21/2007 | EP1753442A2 Method of administering and using vegf inhibitors for the treatment of human cancer |
| 02/21/2007 | EP1753441A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/21/2007 | EP1753411A2 Methods of manufacture and use of calcium phosphate particles containing allergens |
| 02/21/2007 | EP1753404A1 Microspheres comprising protein and showing injectability at high concentrations of said agent |
| 02/21/2007 | EP1534404B1 Use of a clathrate modifier to promote passage of proteins during nanofiltration |
| 02/21/2007 | EP1438066B1 Incapacitated whole-cell immunogenic bacterial compositions |
| 02/21/2007 | EP1390474B1 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 02/21/2007 | EP1292332B1 ADJUVANTS AND PROCESSES TO INDUCE A Th2 IMMUNE RESPONSE |
| 02/21/2007 | EP1290137B1 Virulence genes, proteins, and their use |
| 02/21/2007 | EP1232177B1 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 02/21/2007 | EP1220687B1 Administration of gamma globulins to treat lymphoma |
| 02/21/2007 | EP1212422B1 Human ctla-4 antibodies and their uses |
| 02/21/2007 | EP1206961B1 Filter membranes for physiologically active substances |
| 02/21/2007 | EP1100819B1 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 02/21/2007 | EP1086225B1 Human tumour-derived polypeptide hormone phosphatonin |
| 02/21/2007 | EP1075521B1 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 02/21/2007 | EP1003787B1 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 02/21/2007 | EP0999848B1 Chimeric proteins for the treatment of diabetes |
| 02/21/2007 | EP0954334B1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 02/21/2007 | EP0871485B1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
| 02/21/2007 | EP0815202B1 Human tissue inhibitor of metalloproteinase-4 |
| 02/21/2007 | EP0602046B2 Detection of feline immunodeficiency viruses |
| 02/21/2007 | EP0590126B1 Polypeptides having kinase activity, their preparation and use |
| 02/21/2007 | CN1918293A Substituted non-coding nucleic acid molecule for therapeutic or prophylaxis immunological stimulus for human and higher animal |
| 02/21/2007 | CN1918281A Vaccine for periodontal disease |
| 02/21/2007 | CN1918181A Detection of cd20 in transplant rejection |
| 02/21/2007 | CN1918178A Fc region variants |
| 02/21/2007 | CN1918176A Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/21/2007 | CN1917902A Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/21/2007 | CN1917901A Detection of cd20 in therapy of autoimmune diseases |
| 02/21/2007 | CN1917900A Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same |
| 02/21/2007 | CN1916167A Modulation of peroxisome proliferation-activated receptors |
| 02/21/2007 | CN1915427A Application of fusion protein of VEGF receptor for treating disease of eye |
| 02/21/2007 | CN1915426A Method for producing yelk antibody liquid in high immunity |
| 02/21/2007 | CN1915425A Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/21/2007 | CN1915424A Acellular pertussis vaccines and methods of preparation thereof |
| 02/21/2007 | CN1301267C A simulated epitope peptide of MUC1 mucoprotein and its encoding DNA and use thereof |
| 02/21/2007 | CN1301134C Novel immune effect compound |
| 02/21/2007 | CN1301131C Viral myocarditis gene vaccine, its preparation method and application |
| 02/20/2007 | US7179900 Novel nucleic acid molecules; immunospecifically binding respiratory syncytial virus (RSV) antigens; long half life; reduced dosage and side effects |
| 02/20/2007 | US7179892 Humanized antibodies that recognize beta amyloid peptide |
| 02/20/2007 | US7179888 Antigenic, non-toxic mutants of Clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith |
| 02/20/2007 | US7179849 Antimicrobial compositions containing colloids of oligodynamic metals |
| 02/20/2007 | US7179797 Methods and compositions for treating prostate cancer using DNA vaccines |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | US7179609 Screening method for gastritis |
| 02/20/2007 | US7179608 Therapeutic antiangiogenic compositions and methods |
| 02/20/2007 | US7179493 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 02/20/2007 | US7179474 Methods for treating a buttock deformity |
| 02/20/2007 | US7179473 Attenuated pestiviruses |
| 02/20/2007 | US7179472 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/20/2007 | US7179471 Materials and methods relating to fusion proteins an immune response |
| 02/20/2007 | US7179470 Hepatitis-C virus testing |
| 02/20/2007 | US7179468 Antigen for developing neutralizing antibodies to human immunodeficiency virus |
| 02/20/2007 | US7179467 DCMP2 polypeptide |
| 02/20/2007 | US7179466 Methods of treating rheumatoid arthritis by multiple administration of anti-TNF antibodies |
| 02/20/2007 | US7179465 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type 1 interferon |
| 02/20/2007 | US7179464 Immunoglobulin for use in the treatment and prevention of asthma |
| 02/20/2007 | US7179463 Treatment of alzheimer's disease |
| 02/20/2007 | US7179462 α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof |
| 02/20/2007 | US7179448 Recombinant constructs of Borrelia burgdorferi |
| 02/20/2007 | CA2346997C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 02/20/2007 | CA2289979C Methods of modulating immune coagulation |
| 02/20/2007 | CA2218872C Preparation and use of sulfated oligosaccharides |
| 02/20/2007 | CA2193210C Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
| 02/20/2007 | CA2192512C Nm03 antibody materials and methods |
| 02/15/2007 | WO2007019541A2 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility |
| 02/15/2007 | WO2007019411A2 Peptides for diagnostic and therapeutic methods for celiac sprue |
| 02/15/2007 | WO2007019406A2 Methods for treating and detecting beta-cell disease |
| 02/15/2007 | WO2007019247A2 Virus-like particles as vaccines for paramyxovirus |
| 02/15/2007 | WO2007019232A2 Immunoconjugate formulations |
| 02/15/2007 | WO2007019165A1 Methods and compositions for treating female infertility using clomiphene |
| 02/15/2007 | WO2007019094A2 Modified influenza virus for monitoring and improving vaccine efficiency |
| 02/15/2007 | WO2007019064A2 ANTI-TNFα ANTIBODIES AND METHODS OF USE |
| 02/15/2007 | WO2007018879A2 Interferon-gamma antagonists and therapeutic uses thereof |
| 02/15/2007 | WO2007018853A2 Secretion of antibodies without signal peptides from bacteria |
| 02/15/2007 | WO2007018843A2 Methods and compositions for diagnosis and treatment of influenza |
| 02/15/2007 | WO2007018556A2 Method for detection and decontamination of antigens by nanoparticle-raman spectroscopy |
| 02/15/2007 | WO2007018482A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/15/2007 | WO2007018475A1 Novel anticoagulant polypeptides and complex |
| 02/15/2007 | WO2007018463A2 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 02/15/2007 | WO2007018316A1 Prophylactic/therapeutic agent for cancer |
| 02/15/2007 | WO2007018152A1 ANTIGEN-AND-DRUG VEHICLE WHICH ENABLES THE CHANGEOVER FROM THE SELECTIVE PRODUCTION OF IgA ANTIBODY TO THE PRODUCTION OF BOTH OF IgA AND IgG ANTIBODIES, AND TRANSNASAL/TRANSMUCOSAL VACCINE USING THE VEHICLE |
| 02/15/2007 | WO2007018049A1 Antigen capable of inducing neutralizing antibody for high risk-type human papillomavirus |
| 02/15/2007 | WO2007018047A1 Squamous cell carcinoma antigen-derived peptide binding to hla-a24 molecule |
| 02/15/2007 | WO2007017859A1 Intravenous immunoglobulin composition |
| 02/15/2007 | WO2007017635A1 Immunogenic constructs |
| 02/15/2007 | WO2007017242A2 Novel virus reduction method based on detergents and shearing forces |
| 02/15/2007 | WO2007017154A2 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 02/15/2007 | WO2007016764A1 Composition and method for prevention and treatment of type i diabetes |
| 02/15/2007 | WO2007016715A2 Immune response inducing preparations |
| 02/15/2007 | WO2006138567A3 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma |
| 02/15/2007 | WO2006138509A3 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis |
| 02/15/2007 | WO2006123122A3 Psk- i and its modulators for the treatment/diagnosis of cancer |
| 02/15/2007 | WO2006107944A3 Improved method and apparatus for treating bacterial infections in devices |
| 02/15/2007 | WO2006094756A3 Varicella zoster virus vaccine |
| 02/15/2007 | WO2006081826A3 Survivin peptide vaccine |